Contemporary treatment of ductal carcinoma in situ of the breast

Medical Science Monitor

Volumn 11, Issue 3, 2005, Pages

  Mokbel, Kefah ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

DCIS; Lumpectomy; Mastectomy; Radiotherapy; Tamoxifen; Treatment

Indexed keywords

ACOLBIFENE; ANASTROZOLE; ANTIESTROGEN; FULVESTRANT; PLACEBO; TAMOXIFEN;

BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CARCINOMA IN SITU; CLINICAL TRIAL; FEMALE; HIGH RISK POPULATION; HORMONE SENSITIVITY; HUMAN; MAJOR CLINICAL STUDY; PARTIAL MASTECTOMY; POSTMENOPAUSE; RETROSPECTIVE STUDY; REVIEW;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MAMMAPLASTY; MASTECTOMY; MASTECTOMY, SEGMENTAL; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS; RETROSPECTIVE STUDIES; TAMOXIFEN;

EID: 15944416725     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Shoker BS, Sloane JP: DCIS grading schemes and clinical implications. Histopathology, 1999; 35: 393-400
2. Page DL, Dupont WD, Rogers LW et al: Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated by biopsy. Cancer, 1995; 76: 1197-200
3. Welch HG, Black WC: Using autopsy series to estimate the disease "reservoir" for ductal carcinoma in situ of the breast: how much more breast cancer can we find? Ann Intern Med, 1997; 127: 1023-28
4. Ernster VL, Barclay J, Kerlikowske K et al: Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA, 1996; 275: 913-18
5. Moss SM, Michel M, Patnick J et al: Results from the NHS breast screening programme 1990-1993. J Med Screen, 1995; 2: 186-90
6. Verkooijen HM: Core Biopsy After Radiological Localisation (COBRA) Study Group. Diagnostic accuracy of stereotactic large-core needle biopsy for nonpalpable breast disease: results of a multicenter prospective study with 95% surgical confirmation. Int J Cancer, 2002; 99: 853-59
7. Dahlstrom JE, Jain S: Histological correlation of mammographically detected microcalcifications in stereotactic core biopsies. Pathology, 2001; 33: 444-48
8. Fischer U, Baum F, Obenauer S et al: Comparative study in patients with microcalcifications: full-field digital mammography vs screen-film mammography. Eur Radiol, 2002; 12: 2679-83
9. Bazzocchi M, Facecchia I, Zuiani C et al: Application of a computer-aided detection (CAD) system to digitalized mammograms for identifying microcalcifications. Radiol Med (Torino), 2001; 101: 334-40
10. Hwang ES, Kinkel K, Esserman LJ et al: Magnetic resonance imaging in patients diagnosed with ductal carcinoma-in-situ: value in the diagnosis of residual disease, occult invasion, and multicentricity. Ann Surg Oncol, 2003; 10: 381-88
11. Fisher ER, Sass R, Fisher B et al: Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6). II. Relation of local breast recurrence to multicentricity. Cancer, 1986; 57: 1717-24
12. Silverstein MJ, Barth A, Poller DN et al: Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast. Eur J Cancer, 1995; 31: 1425-27
13. Boyages J, Delaney G, Taylor R: Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis. Cancer, 1999; 85: 616-28
14. Tunon-de-Lara C, de-Mascarel I, Mac-Grogan G et al: Analysis of 676 cases of ductal carcinoma in situ of the breast from 1971 to 1995: diagnosis and treatment-the experience of one institute. Am J Clin Oncol, 2001; 24: 531-36
15. Lagios MD, Margolin FR, Westdahl PR, Rose MR: Mammographically detected duct carcinoma in situ: frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer, 1989; 63: 618-24
16. Schwartz GF, Finkel GC, Garcia JC, Patchefsky AS: Subclinical ductal carcinoma in situ of the breast. Treatment by local excision and surveillance alone. Cancer, 1992; 70: 2468-74
17. Rubio IT, Mirza N, Sahin AA et al: Role of specimen radiography in patients treated with skin-sparing mastectomy for ductal carcinoma in situ of the breast. Ann Surg Oncol, 2000; 7: 544-48
18. Veronesi U, Banfi A, Del Vecchio M et al: Comparison of Halsted mastectomy with quadrantectomy, axillary dissection, and radiotherapy in early breast cancer: long-term results. Eur J Cancer Clin Oncol, 1986; 22: 1085-89
19. Fisher B, Bauer M, Margolese R et al: Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med, 1985; 312: 665-73
20. Schwartz GF, Solin LJ, Olivotto IA et al: The Consensus Conference on the Treatment of In Situ Ductal Carcinoma of the Breast, April 22-25, 1999. The Breast Journal, 2000; 6: 4-13
21. Al-Ghazal SK, Sully L, Fallowfield L, Blarney RW: The psychological impact of immediate rather than delayed breast reconstruction. Eur J Surg Oncol, 2000; 26: 17-19
22. Singletary SE: Skin-sparing mastectomy with immediate breast reconstruction: the M.D. Anderson Cancer Center experience. Ann Surg Oncol, 1996; 3: 411-16
23. Khoo A, Kroll SS, Reece GP et al: A comparison of resource costs of immediate and delayed breast reconstruction. Plast Reconstr Surg, 1998; 101: 964-68
24. Spiegel AJ, Butler CE: Recurrence following treatment of ductal carcinoma in situ with skin-sparing mastectomy and immediate breast reconstruction. Plast Reconstr Surg, 2003; 111: 706-11
25. Rogers NE, Allen RJ. Radiation effects on breast reconstruction with the deep inferior epigastric perforator flap. Plast Reconstr Surg, 2002; 109: 1919-24
26. Petit J, Rietjens M, Garusi C: Breast reconstructive techniques in cancer patients: which ones, when to apply, which immediate and long term risks? Crit Rev Oncol Hematol, 2001; 38: 231-39
27. Fisher B, Constantino J, Redmond C et al: Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer N Engl J Med, 1993; 328: 1581-86
28. Fisher B, Dignam J, Wolmark N et al: Lumpectomy and Radiation Therapy for the Treatment of Intraductal Breast Cancer Findings From National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol, 1998; 16: 441-52
29. Julien J-P, Bijker N, Fentiman S et al: Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomized phase III trial 10853. Lancet, 2000; 355: 528-33
30. No author listed. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Auatralia, and New Zealand: randomised controlled trial. Lancet, 2003; 362: 95-102
31. Silverstein MJ, Lagios MD: Benefits of irradiation for DCIS: a Pyrrhic victory. Lancet, 2000; 355: 510-11
32. Bijker N, Peterse JL, Duchateau L et al: Risk factors for recurrence and Metastasis after breast-conserving therapy for ductal carcinoma in situ: analysis of the European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol, 2001; 19: 2263-71
33. Kestin LL, Goldstern NS, Martinez AA et al: Mammographically detected ductal carcinoma in situ treated with conservative surgery with or without radiation therapy: patterns of failure and 10 year results. Ann Surg, 2000; 231: 235-45
34. Cutuli B, Cohen-Solal-le Nir C, De Lafontan R et al: Ductal carcinoma in situ of the breast; results of conservative and radical treatments in 716 patients. Eur J Cancer, 2001; 37: 2365-72
35. Solin LJ, Kurtz J, Fourquet A et al: Fifteen year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast. J Clin Oncol. 1996; 14: 754-63
36. Sakorafas GH, Tsiotou AG: Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives. Cancer Tret Rev, 2000; 26: 103-25
37. Silverstein MJ: The University of Southern California/Van Nuys prognostic index for ductal carcinoma in situ of the breast. Am J Surg, 2003; 186: 337-43
38. de Mascarel I, Bonichon F, MacGrogan G et al: Application of the van nuys prognostic index in a retrospective series of 367 ductal carcinomas in situ of the breast examined by serial macroscopic sectioning: practical considerations. Breast Cancer Res Treat, 2000; 61: 151-59
39. Silverstein MJ, Lagios MD, Groshen S et al: The influence of margin width on local control of ductal carcinoma of the breast. N Engl J Med, 1999; 340: 1455-61
40. Neuschatz AC, DiPetrillo T, Safaii H et al: Margin width as a determinant of local control with and without radiation therapy for ductal carcinoma in situ (DCIS) of the breast. Int J Cancer, 2001; 96: 97-104.
41. Chan KC, Knox WF, Sinha G et al: Extent of excision margin width required in breast conserving surgery for ductal carcinoma in situ. Cancer, 2001; 91: 9-16
42. Fisher B, Dignam J, Wolmark N et al: Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet, 1999; 353: 1993-2000
43. th Annual San Antonio Breast Cancer Symposium.Curr Med Res Opin, 2003; 19: 143-46
44. Fisher B, Land S, Mamounas E et al: Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the national surgical adjuvant breast and bowel project experience. Semin Oncol, 2001; 28: 400-18
45. Fisher B, Costantino JP, Wickerham DL et al: Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst, 1998; 90: 1371-88
46. Ragaz J, Coldman A: Survival impact of adjuvant tamoxifen on competing causes of mortality in breast cancer survivors, with analysis of mortality from contralateral breast cancer, cardiovascular events, endometrial cancer, and thromboembolic episodes. J Clin Oncol, 1998; 16: 2018-24
47. Elkak AE, Mokbel K: Pure antiestrogens and breast cancer. Curr Med Res Opin, 2001; 17: 282-89
48. Mokbel K: The evolving role of aromatase inhibitors in breast cancer. Int J Clin Oncol, 2002; 7: 279-83
49. The ATAC Trialists Group: Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial. Lancet, 2002; 359: 2131-39
50. Zhang Z, Yamashita H, Toyama T et al: Semi-quantitative immunohistochemical analysis of aromatase expression in ductal carcinoma in situ of the breast Breast Cancer Res Treat, 2002; 74: 47-53
51. Singh-Ranger G, Mokbel K: The role of cyclooxygenase-2 (COX-2) in breast cancer, and implications of COX-2 inhibition. Eur J Surg Oncol, 2002; 28: 729-37
52. Singh-Ranger G, Mokbel K: Current concepts in cyclooxygenase inhibition in breast cancer. J Clin Pharm Ther, 2002; 27: 321-27
53. Singh-Ranger G, Mokbel K: The evolving role of sentinel lymph node biopsy for breast cancer. Eur J Surg Oncol, 2003; 29: 423-25
54. Klauber-DeMore N, Tan LK, Liberman L et al: Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with micro-invasion? Ann Surg Oncol, 2000; 7: 636-42
55. Cox CE, Nguyen K, Gray RJ et al: Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS? Am Surg, 2001; 67: 513-19
56. Intra M, Veronesi P, Mazzarol G et al: Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. Arch Surg, 2003; 138: 309-13
57. Mokbel K, Elkak A: The evolving role of mammary ductoscopy. Curr Med Res Opin, 2002; 18: 30-32
58. Dooley WC: Routine operative breast endoscopy for bloody nipple discharge. Ann Surg Oncol, 2002; 9: 920-23
59. Dowlatshahi K, Francescatti DS, Bloom KJ: Laser therapy for small breast cancers. Am J Surg, 2002; 184: 359-63
60. Luzzi V, Holtschlag V, Watson MA: Expression profiling of ductal carcinoma in situ by laser capture microdissection and high density oligonucleotide arrays. Am J Pathol, 2001; 158: 2005-10
61. Wulfkuhle JD, Sgroi DC, Krutzsch H et al: Proteomics of human breast ductal carcinoma in situ. Cancer Res, 2002; 62: 6740-49
62. Heiken TJ, Farolan M, D'alessandro S, Velasco JM: Predicting the biologic behaviour of ductal carcinoma in situ: An analysis of molecular markers. Surg, 2001; 30: 593-601
63. Hoque A, Sneige N, Sahin AA et al: Her-2/neu gene amplification in ductal carcinoma in situ of the breast. Cancer Epidemiol Biomarkers Prev, 2002; 11: 587-90
64. Cwikla J, Buscombe JR, Hilson AJ: Detection of DCIS using 99mTc-MIBI scintimammography in patients with suspected primary breast cancer, comparison with conventional mammography. Nucl Med Rev Cent East Eur, 2000; 3: 41-45
65. Veronesi U, Gatti G, Luini A et al: Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery. Arch Surg, 2003; 138: 1253-56